CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 72 filers reported holding CATALYST BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -28.6% | 45,915 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $42,000 | -77.8% | 45,915 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $189,000 | -34.4% | 45,915 | -30.9% | 0.01% | -44.4% |
| Q2 2021 | $288,000 | -16.5% | 66,425 | -2.9% | 0.01% | -30.8% |
| Q1 2021 | $345,000 | +48.1% | 68,425 | +72.1% | 0.01% | -18.8% |
| Q2 2020 | $233,000 | -65.1% | 39,750 | -30.4% | 0.02% | -72.4% |
| Q2 2018 | $667,000 | +4.9% | 57,144 | +131.8% | 0.06% | -22.7% |
| Q1 2018 | $636,000 | – | 24,652 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |